The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD

Volume: 54, Issue: 6, Pages: 1900521 - 1900521
Published: Sep 19, 2019
Abstract
Inhaled corticosteroids (ICS) are widely prescribed for patients with chronic obstructive pulmonary disease (COPD), yet have variable outcomes and adverse reactions, which may be genetically determined. The primary aim of the study was to identify the genetic determinants for forced expiratory volume in 1 s (FEV 1 ) changes related to ICS therapy. In the Lung Health Study (LHS)-2, 1116 COPD patients were randomised to the ICS triamcinolone...
Paper Details
Title
The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD
Published Date
Sep 19, 2019
Volume
54
Issue
6
Pages
1900521 - 1900521
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.